Sunday, December 14, 2025

Press Release: Cerner To Work with DrFirst to Connect to State Prescription Drug Monitoring Programs

“Cerner (Nasdaq: CERN), a global health platform and innovation company, and DrFirst, a leading provider of medication management and data solutions, are working together on a new and innovative offering to help providers tackle the opioid epidemic. By streamlining the connection from a person’s electronic health record (EHR) to each state’s prescription drug monitoring program (PDMP) database, physicians will have nationwide access to patient prescription drug information.”

“With DrFirst, Cerner will be able to connect the EHR to PDMPs in 46 states and Washington, D.C., with other states expected as they become available. Prescription drug and dispensed information collected in these state-specific databases are used to inform safer prescribing, support drug education efforts, research drug addiction and prevent substance use disorder. Assisting physicians to more effectively and efficiently connect to PDMPs helps support safer pain management, identify and mitigate risk factors and more easily manage populations at high risk for substance use disorder.” Read the full press release here.

Source: Cerner To Work with DrFirst to Connect to State Prescription Drug Monitoring Programs – May 14, 2019. DrFirst.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Innovation in Action: Advancing Government Health with Philips

FORUM is proud to partner with Philips for a series of articles on their groundbreaking innovations in health technology that serve public- and private sector citizens and service members. Please take a look to learn more about how Philips is advancing modern and efficient health care, while improving lives for generations to come.

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required